Stockholm is tense. The Royal Swedish Academy of Sciences will soon name the next Nobel laureate in chemistry. The European Academies Science Advisory Council confirms the official announcement is set for 11:45 CEST. As of October 7, 2026, the prize had not been awarded. Every scientist named so far is still just a forecast, not an official nominee or winner.
Last year, the Nobel went to Susumu Kitagawa, Richard Robson, and Omar Yaghi. Their work on metal-organic frameworks changed the game for carbon capture, toxic gas storage, and pulling water from dry air. These advances are detailed in a PBS NewsHour report. This year, the focus has shifted. Two fields stand out: metabolic signals and gene editing.
Nominations for the Nobel Prize remain secret for 50 years, so public lists of favorites reflect expert predictions, not official information from the Nobel Committee.
Metabolic molecules: GLP-1 in the running
Scientists who cracked the biology of glucagon-like peptide 1 (GLP-1) are now top contenders. This hormone is the backbone of blockbuster weight-loss drugs like Wegovy and Mounjaro. Clarivate analysts first tipped GLP-1 research for the Nobel in Medicine. That didn’t happen. The prize went to neuroscientists. Still, David Pendlebury of Clarivate says GLP-1 “could receive a chemistry prize.” The reason is simple. GLP-1 changed how doctors treat metabolic disease. Daniel Drucker, Jens Juul Holst, and Svetlana Mojsov are the names most often cited for this work. They are well known in endocrinology and chemical biology, as Nordic Life Science reporting shows.
GLP-1’s path from hormone discovery to drug therapy is a classic Nobel story. The hormone controls appetite. Turning it into a drug reshaped obesity treatment. It also changed the business of metabolic drugs. Big impact. Big money.
Gene editing and nanoscale coatings
Gene editing is another strong candidate. David Liu stands out. He didn’t invent classic CRISPR. Instead, he pioneered base editing and prime editing. These methods let scientists make precise changes to DNA without breaking both strands. That’s a big leap. Details are in a Cuestión de Química analysis. The chemistry Nobel has often gone to new molecular tools. Gene editing fits that pattern.
Clarivate also points to self-assembled monolayers (SAMs). These are molecular coatings that let scientists control surfaces at the nanoscale. David Allara, Ralph Nuzzo, and Jacob Sagiv lead this field. Their work opened new doors in materials science and nanotech.
At the time of independent reporting on October 7, 2026, the Nobel Prize in Chemistry had not yet been announced, and all listed scientists were considered as forecasted contenders rather than official nominees or laureates.
These advances echo other breakthroughs. For example, the recent mapping of Alzheimer’s disease at the single-cell level opened new paths for diagnosis and therapy. The pattern is clear. Molecular tools are changing medicine.
What’s at stake
The Nobel Prize in Chemistry often signals where molecular science is heading. This year’s favorites—whether for decoding appetite or inventing new gene tools—show how basic discovery meets real-world change. The Academy’s pick will do more than honor a scientist. It will show which direction biotech is moving. In a world where molecules drive both medicine and markets, the Nobel spotlight matters. It points to the future of chemical biology.
